Unaudited Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenues
Product revenue, net	$ 100,106,000	$ 68,864,000	$ 187,255,000	$ 131,661,000
Collaboration revenue	398,000	0	398,000	0
Total revenues	100,504,000	68,864,000	187,653,000	131,661,000
Expenses
Cost of product revenue	(35,148,000)	(23,763,000)	(68,767,000)	(45,100,000)
Cost of collaboration revenue	(85,000)	0	(85,000)	0
Research and development	(61,625,000)	(76,682,000)	(116,270,000)	(125,153,000)
Selling, general, and administrative	(79,710,000)	(67,920,000)	(148,904,000)	(130,430,000)
Gain on sale of intellectual property	0	10,000,000	0	10,000,000
Loss from operations	(76,064,000)	(89,501,000)	(146,373,000)	(159,022,000)
Interest income	9,330,000	10,090,000	18,988,000	20,321,000
Interest expense	(492,000)	0	(605,000)	0
Foreign currency losses	(4,108,000)	(40,079,000)	(6,176,000)	(31,167,000)
Other (expenses) income, net	(8,943,000)	(1,405,000)	418,000	(171,000)
Loss before income tax	(80,277,000)	(120,895,000)	(133,748,000)	(170,039,000)
Income tax expense	0	0	0	0
Net loss	$ (80,277,000)	$ (120,895,000)	$ (133,748,000)	$ (170,039,000)
Loss per share - basic (in dollars per share)	$ (0.08)	$ (0.13)	$ (0.14)	$ (0.18)
Loss per share - diluted (in dollars per share)	$ (0.08)	$ (0.13)	$ (0.14)	$ (0.18)
Weighted-average shares used in calculating net loss per ordinary share - basic (in shares)	975,937,790	964,817,310	974,541,780	963,140,360
Weighted-average shares used in calculating net loss per ordinary share - diluted (in shares)	975,937,790	964,817,310	974,541,780	963,140,360